SMO and pancreatic neoplasm: Notably, inhibition of Hh-Smo signalling in tumour-associated stromal cells upon application of either a Smo chemical inhibitor or a neutralising anti-Hh antibody substantially attenuated growth of colon and pancreatic tumour cells in vivo [49,54,55].